未登录

H

Hao Cai

chinese academy of medical sciences - peking union medical college

H指数:18

被引数:938

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Efficacy and safety of pegylated interferon in the treatment of JAK2V617F-positive polycythemia vera with a dose de-escalation strategy: a single-center retrospective study

聚乙二醇干扰素治疗JAK2V617F阳性真性红细胞增多症的安全性和有效性及剂量递减策略：一项单中心回顾性研究

FRONTIERS IN ONCOLOGY

IF3.3

2025-05-140

OA

Neutrophil-related immune-inflammatory biomarkers influence the early progression of medial medullary infarction

中性粒细胞相关的免疫炎症生物标志物影响延髓内侧梗死早期的进展

FRONTIERS IN NEUROLOGY

IF2.8

2025-02-260

OA

Impact of DNA Extraction Methods on Gut Microbiome Profiles: A Comparative Metagenomic Study

IF6.2

2025-02-200

PRE

The Role of Next-Generation Sequencing in Predicting Early Relapse for Newly Diagnosed Multiple Myeloma Patients Treated with VRD Regimen

下一代测序在预测接受VRD方案治疗的新诊断多发性骨髓瘤患者早期复发中的作用

IF23.1

2024-11-050

PRE

Lenalidomide and dexamethasone for Rosai-Dorfman disease: a single arm, single center, prospective phase 2 study

ECLINICALMEDICINE

IF10

2024-07-010

OAAI

Co-occurrence of Erdheim-Chester disease and clonally evolving acute myeloid leukemia with FLT3-ITD and PTPN11 mutations

ANNALS OF HEMATOLOGY

IF2.4

2024-06-150

PRE

Serum CXCL13 level is related to treatment response and predicts disease prognosis in Waldenström macroglobulinemia

ANNALS OF HEMATOLOGY

IF2.4

2024-03-060

PRE

Phase 2 study using low dose cytarabine for adult patients with newly diagnosed Langerhans cell histiocytosis

IF13.4

2024-02-223

PRE

Germline defects of familial hemophagocytic lymphohistiocytosis-related genes presenting as adult-onset peripheral T-cell lymphoma

FRONTIERS IN IMMUNOLOGY

IF5.9

2024-02-090

OAAI

Clinical phenotypes, molecular analysis, and outcomes of patients with Rosai-Dorfman disease

IF13.4

2023-09-202

PRE

Isolation, Structure Elucidation, and First Total Synthesis of Quinomycins K and L, Two New Octadepsipeptides from the Maowei Sea Mangrove-Derived Streptomyces sp. B475

IF5.4

2023-02-234

OAAI

Langerhans cell histiocytosis in adolescent patients: a single-centre retrospective study

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2022-07-153

OAAI

Adult Langerhans cell histiocytosis with thyroid gland involvement: clinical presentation, genomic analysis, and outcome

甲状腺受累的成人朗格汉斯细胞组织细胞增生症: 临床表现，基因组分析和结果

ANNALS OF HEMATOLOGY

IF2.4

2022-07-026

PRE

The potential of cell-free DNA to reveal the molecular profiles of Langerhans cell histiocytosis and Erdheim-Chester disease in adults

IF13.4

2022-02-162

PRE

Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis

ORPHANET JOURNAL OF RARE DISEASES

IF3.5

2022-02-070

OAAI

Metabolomics Tools Assisting Classic Screening Methods in Discovering New Antibiotics from Mangrove Actinomycetia in Leizhou Peninsula

IF5.4

2021-12-0118

OAAI

Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2021-11-2331

OA

Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis

IF13.4

2021-10-0534

PREAI

Treatment and outcomes of POEMS syndrome: changes in the past 20 years

BLOOD CANCER JOURNAL

IF11.6

2021-08-1411

OAAI

Bortezomib plus dexamethasone as first-line therapy for patients with POEMS syndrome

ANNALS OF HEMATOLOGY

IF2.4

2021-07-3117

PRE